In situ metabolomic mass spectrometry imaging: Recent advances and difficulties

Daisuke Miura, Yoshinori Fujimura, Hiroyuki Wariishi

Research output: Contribution to journalReview article

80 Citations (Scopus)

Abstract

MS imaging (MSI) is a remarkable new technology that enables us to determine the distribution of biological molecules present in tissue sections by direct ionization and detection. This technique is now widely used for in situ imaging of endogenous or exogenous molecules such as proteins, lipids, drugs and their metabolites, and it is a potential tool for pathological analysis and the investigation of disease mechanisms. MSI is also thought to be a technique that could be used for biomarker discovery with spatial information. The application of MSI to the study of endogenous metabolites has received considerable attention because metabolites are the result of the interactions of a system's genome with its environment and a total set of these metabolites more closely represents the phenotype of an organism under a given set of conditions. Recent studies have suggested the importance of in situ metabolite imaging in biological discovery and biomedical applications, but several issues regarding the technical application limits of MSI still remained to be resolved. In this review, we describe the capabilities of the latest MSI techniques for the imaging of endogenous metabolites in biological samples, and also discuss the technical problems and new challenges that need to be addressed for effective and widespread application of MSI in both preclinical and clinical settings.This article is part of a Special Issue entitled: Imaging Mass Spectrometry: A User's Guide to a New Technique for Biological and Biomedical Research.

Original languageEnglish
Pages (from-to)5052-5060
Number of pages9
JournalJournal of Proteomics
Volume75
Issue number16
DOIs
Publication statusPublished - Aug 30 2012

Fingerprint

Metabolomics
Mass spectrometry
Biomedical Research
Mass Spectrometry
Biomarkers
Genome
Technology
Phenotype
Lipids
Imaging techniques
Metabolites
Pharmaceutical Preparations
Proteins
Molecules
Ionization
Genes
Tissue

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry

Cite this

In situ metabolomic mass spectrometry imaging : Recent advances and difficulties. / Miura, Daisuke; Fujimura, Yoshinori; Wariishi, Hiroyuki.

In: Journal of Proteomics, Vol. 75, No. 16, 30.08.2012, p. 5052-5060.

Research output: Contribution to journalReview article

Miura, Daisuke ; Fujimura, Yoshinori ; Wariishi, Hiroyuki. / In situ metabolomic mass spectrometry imaging : Recent advances and difficulties. In: Journal of Proteomics. 2012 ; Vol. 75, No. 16. pp. 5052-5060.
@article{39027046fda14f70aba662fc137551a9,
title = "In situ metabolomic mass spectrometry imaging: Recent advances and difficulties",
abstract = "MS imaging (MSI) is a remarkable new technology that enables us to determine the distribution of biological molecules present in tissue sections by direct ionization and detection. This technique is now widely used for in situ imaging of endogenous or exogenous molecules such as proteins, lipids, drugs and their metabolites, and it is a potential tool for pathological analysis and the investigation of disease mechanisms. MSI is also thought to be a technique that could be used for biomarker discovery with spatial information. The application of MSI to the study of endogenous metabolites has received considerable attention because metabolites are the result of the interactions of a system's genome with its environment and a total set of these metabolites more closely represents the phenotype of an organism under a given set of conditions. Recent studies have suggested the importance of in situ metabolite imaging in biological discovery and biomedical applications, but several issues regarding the technical application limits of MSI still remained to be resolved. In this review, we describe the capabilities of the latest MSI techniques for the imaging of endogenous metabolites in biological samples, and also discuss the technical problems and new challenges that need to be addressed for effective and widespread application of MSI in both preclinical and clinical settings.This article is part of a Special Issue entitled: Imaging Mass Spectrometry: A User's Guide to a New Technique for Biological and Biomedical Research.",
author = "Daisuke Miura and Yoshinori Fujimura and Hiroyuki Wariishi",
year = "2012",
month = "8",
day = "30",
doi = "10.1016/j.jprot.2012.02.011",
language = "English",
volume = "75",
pages = "5052--5060",
journal = "Journal of Proteomics",
issn = "1874-3919",
publisher = "Elsevier",
number = "16",

}

TY - JOUR

T1 - In situ metabolomic mass spectrometry imaging

T2 - Recent advances and difficulties

AU - Miura, Daisuke

AU - Fujimura, Yoshinori

AU - Wariishi, Hiroyuki

PY - 2012/8/30

Y1 - 2012/8/30

N2 - MS imaging (MSI) is a remarkable new technology that enables us to determine the distribution of biological molecules present in tissue sections by direct ionization and detection. This technique is now widely used for in situ imaging of endogenous or exogenous molecules such as proteins, lipids, drugs and their metabolites, and it is a potential tool for pathological analysis and the investigation of disease mechanisms. MSI is also thought to be a technique that could be used for biomarker discovery with spatial information. The application of MSI to the study of endogenous metabolites has received considerable attention because metabolites are the result of the interactions of a system's genome with its environment and a total set of these metabolites more closely represents the phenotype of an organism under a given set of conditions. Recent studies have suggested the importance of in situ metabolite imaging in biological discovery and biomedical applications, but several issues regarding the technical application limits of MSI still remained to be resolved. In this review, we describe the capabilities of the latest MSI techniques for the imaging of endogenous metabolites in biological samples, and also discuss the technical problems and new challenges that need to be addressed for effective and widespread application of MSI in both preclinical and clinical settings.This article is part of a Special Issue entitled: Imaging Mass Spectrometry: A User's Guide to a New Technique for Biological and Biomedical Research.

AB - MS imaging (MSI) is a remarkable new technology that enables us to determine the distribution of biological molecules present in tissue sections by direct ionization and detection. This technique is now widely used for in situ imaging of endogenous or exogenous molecules such as proteins, lipids, drugs and their metabolites, and it is a potential tool for pathological analysis and the investigation of disease mechanisms. MSI is also thought to be a technique that could be used for biomarker discovery with spatial information. The application of MSI to the study of endogenous metabolites has received considerable attention because metabolites are the result of the interactions of a system's genome with its environment and a total set of these metabolites more closely represents the phenotype of an organism under a given set of conditions. Recent studies have suggested the importance of in situ metabolite imaging in biological discovery and biomedical applications, but several issues regarding the technical application limits of MSI still remained to be resolved. In this review, we describe the capabilities of the latest MSI techniques for the imaging of endogenous metabolites in biological samples, and also discuss the technical problems and new challenges that need to be addressed for effective and widespread application of MSI in both preclinical and clinical settings.This article is part of a Special Issue entitled: Imaging Mass Spectrometry: A User's Guide to a New Technique for Biological and Biomedical Research.

UR - http://www.scopus.com/inward/record.url?scp=84865158500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865158500&partnerID=8YFLogxK

U2 - 10.1016/j.jprot.2012.02.011

DO - 10.1016/j.jprot.2012.02.011

M3 - Review article

C2 - 22366554

AN - SCOPUS:84865158500

VL - 75

SP - 5052

EP - 5060

JO - Journal of Proteomics

JF - Journal of Proteomics

SN - 1874-3919

IS - 16

ER -